Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986011 · ClinicalTrials.gov registry record
Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families
A clinical trial of Obesity and Healthy, no Evidence of Disease, sponsored by University of Southern California.
- Completed
- Registry status
- 780
- Enrollment target
- 1
- Study location
NCT00986011: Completed study of Obesity and Healthy, no Evidence of Disease, sponsored by University of Southern California.
NCT00986011 is a study of Obesity and Healthy, no Evidence of Disease that has completed, run by University of Southern California. The registered enrollment target is 780 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986011, a study of Obesity and Healthy, no Evidence of Disease, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 780 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Overweight and obesity have been associated with multiple types of disease, including cancer. Living in a smart growth community may encourage behaviors that would reduce the risk of obesity. PURPOSE: This research study is looking at the effect of a smart growth community on prevention of obesity in middle-, moderately low- and low-income families.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER survey administration
- OTHER study of socioeconomic and demographic variables
- PROCEDURE study of high risk factors
Study Locations (1)
California
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2008-04 |
| Est. Completion | 2013-02 |
What the finished NCT00986011 record still lists
NCT00986011 is an observational study that tracks outcomes without assigning an intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which questionnaire administration is the first listed.
NCT00986011 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00986011 about?
NCT00986011 is a clinical study titled "Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families". RATIONALE: Overweight and obesity have been associated with multiple types of disease, including cancer. Living in a smart growth community may encourage behaviors that would reduce the risk of obesity. PURPOSE: This research study is looking at the effect of a smart growth community on prevention ...
What is the current status of trial NCT00986011?
This trial is currently completed. The enrollment target is 780 participants. The study started on 2008-04. Estimated completion is 2013-02.
What conditions does trial NCT00986011 study?
This clinical trial studies the following conditions: Obesity, Healthy, no Evidence of Disease, Weight Changes.
What interventions are being tested in trial NCT00986011?
The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), study of socioeconomic and demographic variables (OTHER), study of high risk factors (PROCEDURE).
Who is sponsoring clinical trial NCT00986011?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00986011 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00986011's enrollment target sits among peer trials
780 96th of 1053 higher than 958 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia